Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Database Management Systems | 1 | 2017 | 32 | 0.70 | Why? |
| Platelet Transfusion | 1 | 2019 | 209 | 0.68 | Why? |
| Transfusion Reaction | 1 | 2019 | 245 | 0.64 | Why? |
| Clinical Laboratory Services | 1 | 2020 | 781 | 0.52 | Why? |
| Biomedical Technology | 1 | 2017 | 257 | 0.52 | Why? |
| Computer Security | 1 | 2017 | 408 | 0.50 | Why? |
| Medical Informatics | 1 | 2020 | 648 | 0.48 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.32 | Why? |
| Administrative Claims, Healthcare | 1 | 2017 | 124 | 0.17 | Why? |
| Insurance Claim Review | 1 | 2017 | 108 | 0.17 | Why? |
| Nucleocapsid | 1 | 2021 | 734 | 0.16 | Why? |
| Polymerase Chain Reaction | 2 | 2021 | 6740 | 0.15 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.14 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.13 | Why? |
| Reagent Kits, Diagnostic | 2 | 2021 | 2149 | 0.13 | Why? |
| Equipment and Supplies | 1 | 2018 | 440 | 0.13 | Why? |
| Diffusion of Innovation | 1 | 2017 | 440 | 0.13 | Why? |
| Sex Characteristics | 1 | 2020 | 1120 | 0.12 | Why? |
| Data Mining | 1 | 2018 | 767 | 0.12 | Why? |
| Confidentiality | 1 | 2017 | 581 | 0.12 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.11 | Why? |
| Decision Support Techniques | 1 | 2018 | 903 | 0.11 | Why? |
| Histone Deacetylases | 1 | 2010 | 37 | 0.11 | Why? |
| Proteome | 1 | 2021 | 1812 | 0.11 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.10 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.10 | Why? |
| Acute Kidney Injury | 2 | 2021 | 5762 | 0.10 | Why? |
| Candida albicans | 1 | 2010 | 217 | 0.09 | Why? |
| Patient Readmission | 1 | 2018 | 1543 | 0.09 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.09 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.08 | Why? |
| T-Lymphocytes | 2 | 2020 | 6670 | 0.08 | Why? |
| Bacterial Infections | 1 | 2019 | 2229 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Electronic Health Records | 1 | 2017 | 3492 | 0.07 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.06 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.06 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.06 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.06 | Why? |
| Patient Discharge | 1 | 2018 | 5696 | 0.06 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.06 | Why? |
| Humans | 18 | 2021 | 930598 | 0.06 | Why? |
| Percutaneous Coronary Intervention | 1 | 2018 | 3646 | 0.06 | Why? |
| Virus Diseases | 1 | 2019 | 3779 | 0.06 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.05 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.05 | Why? |
| Interleukin-5 | 1 | 2020 | 138 | 0.05 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.05 | Why? |
| Antigens, Surface | 1 | 2021 | 181 | 0.05 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.05 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.05 | Why? |
| Interleukin-13 | 1 | 2020 | 204 | 0.05 | Why? |
| Diuretics | 1 | 2021 | 326 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Emergency Service, Hospital | 2 | 2021 | 14232 | 0.05 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.05 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.05 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.04 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
| Infant, Newborn | 1 | 2019 | 23105 | 0.04 | Why? |
| Complement System Proteins | 1 | 2021 | 380 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2020 | 557 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| Organ Specificity | 1 | 2021 | 1070 | 0.04 | Why? |
| Vasoconstrictor Agents | 1 | 2021 | 714 | 0.04 | Why? |
| Product Surveillance, Postmarketing | 1 | 2018 | 189 | 0.04 | Why? |
| Infant | 1 | 2019 | 30274 | 0.04 | Why? |
| Male | 9 | 2021 | 367725 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.03 | Why? |
| Creatinine | 1 | 2021 | 1443 | 0.03 | Why? |
| Chemokines | 1 | 2020 | 1095 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Eosinophils | 1 | 2020 | 848 | 0.03 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.03 | Why? |
| Length of Stay | 2 | 2021 | 11042 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Information Storage and Retrieval | 1 | 2018 | 644 | 0.03 | Why? |
| Protective Factors | 1 | 2018 | 1720 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.03 | Why? |
| Hyphae | 1 | 2010 | 22 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2018 | 1276 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.03 | Why? |
| Infection Control | 1 | 2019 | 23131 | 0.02 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Child | 1 | 2019 | 70012 | 0.02 | Why? |
| Phenotype | 1 | 2020 | 4037 | 0.02 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.02 | Why? |
| United States | 3 | 2021 | 46150 | 0.02 | Why? |
| Adult | 3 | 2021 | 244371 | 0.02 | Why? |
| Mutagenesis | 1 | 2010 | 394 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Monocytes | 1 | 2020 | 2978 | 0.02 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.02 | Why? |
| Hydrogen-Ion Concentration | 1 | 2010 | 993 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Renal Insufficiency, Chronic | 1 | 2021 | 2654 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Brazil | 1 | 2021 | 12582 | 0.02 | Why? |
| Renal Dialysis | 1 | 2021 | 4358 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2021 | 10998 | 0.02 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.02 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Mice | 1 | 2021 | 21357 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Animals | 1 | 2021 | 78931 | 0.01 | Why? |
| Mutation | 1 | 2010 | 12376 | 0.01 | Why? |
Schulz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(125)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(164)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_